Squarepoint
JNJ icon

Squarepoint’s Johnson & Johnson JNJ Stock Holding History

Squarepoint’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102M Sell
418,500
-72,600
-15% -$16.9M 0.12% 161
2025
Q4 		$102M Buy
491,100
+3,500
+0.7% +$692K 0.11% 200
2025
Q3 		$90.4M Sell
487,600
-501,900
-51% -$86M 0.09% 237
2025
Q2 		$151M Buy
989,500
+552,500
+126% +$84.9M 0.16% 122
2025
Q1 		$72.5M Buy
437,000
+165,300
+61% +$25.9M 0.09% 234
2024
Q4 		$39.3M Buy
271,700
+48,600
+22% +$7.53M 0.04% 465
2024
Q3 		$36.2M Buy
223,100
+184,300
+475% +$29.4M 0.06% 349
2024
Q2 		$5.67M Sell
38,800
-102,000
-72% -$15.2M 0.01% 1286
2024
Q1 		$22.3M Buy
140,800
+111,800
+386% +$17.8M 0.04% 570
2023
Q4 		$4.55M Sell
29,000
-62,300
-68% -$9.55M 0.01% 1453
2023
Q3 		$14.2M Buy
91,300
+45,600
+100% +$7.52M 0.04% 615
2023
Q2 		$7.56M Sell
45,700
-3,100
-6% -$500K 0.02% 825
2023
Q1 		$7.56M Buy
48,800
+21,600
+79% +$3.49M 0.03% 676
2022
Q4 		$4.8M Sell
27,200
-8,600
-24% -$1.48M 0.02% 864
2022
Q3 		$5.85M Buy
35,800
+11,100
+45% +$1.88M 0.03% 667
2022
Q2 		$4.38M Buy
24,700
+13,300
+117% +$2.37M 0.02% 755
2022
Q1 		$2.02M Sell
11,400
-24,800
-69% -$4.22M 0.01% 1160
2021
Q4 		$6.19M Buy
36,200
+500
+1% +$81.9K 0.02% 707
2021
Q3 		$5.77M Buy
35,700
+8,900
+33% +$1.52M 0.02% 712
2021
Q2 		$4.42M Buy
26,800
+2,800
+12% +$464K 0.02% 777
2021
Q1 		$3.94M Buy
24,000
+21,100
+728% +$3.41M 0.02% 736
2020
Q4 		$456K Sell
2,900
-1,500
-34% -$221K ﹤0.01% 1880
2020
Q3 		$655K Buy
4,400
+600
+16% +$88.8K 0.01% 1229
2020
Q2 		$534K Buy
+3,800
New +$554K 0.01% 1288
2020
Q1 		– Sell
-5,200
Closed -$759K – 2184
2019
Q4 		$759K Buy
5,200
+2,000
+63% +$271K ﹤0.01% 1504
2019
Q3 		$414K Buy
3,200
+1,400
+78% +$184K ﹤0.01% 1715
2019
Q2 		$251K Sell
1,800
-1,000
-36% -$138K ﹤0.01% 2002
2019
Q1 		$391K Buy
+2,800
New +$375K ﹤0.01% 1618

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Squarepoint's JNJ Position: Q1 2026 in Review

Squarepoint increased its Johnson & Johnson (JNJ) stake by 129% in Q1 2026, buying an estimated $95.6M and bringing the position to 728,993 shares worth $178M. The position accounts for 0.21% of the portfolio, ranked #69.

Squarepoint first reported a position in JNJ in Q1 2016 and has held it in 37 quarters since. The position peaked at $208M in Q1 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Squarepoint held 728,993 shares of Johnson & Johnson worth $178M as of Q1 2026.
  • Squarepoint bought 410,247 Johnson & Johnson shares in Q1 2026, an estimated $95.6M.
  • Johnson & Johnson made up 0.21% of Squarepoint's portfolio in Q1 2026, its #69 holding.
  • Squarepoint first reported a position in Johnson & Johnson in Q1 2016 and has held it in 37 quarters since.
  • Squarepoint's Johnson & Johnson position peaked at $208M in Q1 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.